Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (BBA-RC)

Biochimica et Biophysica Acta (BBA) – Reviews on Cancer is a specialized journal section published by Elsevier that compiles critical, in‑depth review articles summarizing the most important recent advances in cancer research and oncology at the molecular and biochemical level. Established in 1974, it grew out of the broader Biochimica et Biophysica Acta family to provide a forum for comprehensive evaluations of emerging concepts in oncogene function, tumor suppressor gene biology, control of cell proliferation, mechanisms of carcinogenesis, cellular transformation, signalling pathways, immunologic control, and genetic regulation in cancer. Reviews are typically invited and written by experts, offering state‑of‑the‑art analyses rather than original experimental data. The journal helps shape understanding of cancer mechanisms and therapeutic opportunities, bridging basic molecular biology insights with clinical and translational relevance. While each issue is part of the overall BBA volume numbering, Reviews on Cancer appears regularly throughout the year with approximately six issues. Topics often include integrative perspectives on how genetic, biochemical, and signalling influences drive tumor development and progression, as well as discussions of emerging therapeutic targets and strategies. Indexed in major scientific databases, the journal serves researchers, clinicians, and graduate‑level scientists seeking authoritative reviews in cancer biology and molecular oncology.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (BBA-RC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Genetics, Cancer Research, Oncology, tumor suppressor gene biology, control of cell proliferation, mechanisms of carcinogenesis, cellular transformation, signalling pathways, immunologic control, genetic regulation in cancer , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0304-419X, E-ISSN: 1879-2561, Established: 1974, Impact Factor: 8.3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE